Over the last few years, a growing number of cancer patients and advocates have turned their attention to two surprising drugs: ivermectin and fenbendazole. Both are best known as antiparasitic medications — ivermectin for treating river blindness and certain worm infections in humans, and fenbendazole as a dewormer for animals. But can these drugs, especially when used together, really kill cancer? Let’s break down what we know, what we don’t, and why the truth is more complicated than social media headlines would have you believe.
Why the Buzz?
Interest in “repurposed” drugs for cancer is nothing new, but ivermectin and fenbendazole have gained particular traction thanks to online testimonials, podcasts, and a handful of lab studies. High-profile mentions — including from celebrities — have stoked the idea that these cheap, old drugs might hold untapped cancer-fighting power (Oncology News Central).
What Does the Science Show?
Ivermectin: There’s real laboratory evidence that ivermectin can slow the growth of cancer cells, inhibit their spread, and even help overcome resistance to chemotherapy — but these results have been seen in petri dishes and animal models, not in people (PMC - NIH). Reviews highlight its “powerful antitumor effects,” but also caution there’s no proof yet from large, controlled clinical trials that it helps humans with cancer (Ovid).
Fenbendazole: Like ivermectin, fenbendazole has shown it can disrupt cancer cell growth in lab studies. It seems to mess with microtubules inside cells, causing them to die. But again — and this is crucial — there is no robust, peer-reviewed evidence from human clinical trials that fenbendazole works as a cancer treatment. The American Cancer Society is clear: fenbendazole has not been tested or approved for use in humans as a cancer treatment, and any benefits remain unproven (American Cancer Society).
The Combination: There’s no published clinical evidence that using ivermectin and fenbendazole together provides any added benefit, or that the combination “kills cancer” more effectively than either drug alone. Most of the claims you’ll see online are anecdotal or based on personal stories, not rigorous science (Pharmacy Times).
What About Side Effects and Risks?
Both drugs have side effects — some mild, some potentially serious. Ivermectin can cause skin rashes, dizziness, and gastrointestinal issues in some people (GoodRx). Fenbendazole, though used safely in animals, has been linked to liver inflammation and damage in a handful of people who took it for cancer, according to case reports (American Cancer Society). The bottom line: these are not benign supplements, and their safety in humans — especially in the context of cancer — is unproven.
Why Are Experts Cautious?
Doctors and cancer researchers are watching this trend closely, but urge caution. The gap between what happens in a petri dish and what happens in a human body is huge. Until well-designed clinical trials are done, it’s impossible to know if these drugs help or harm people with cancer. Using untested drugs can also interfere with standard treatments and may have unforeseen consequences (Patient Power).
The Takeaway
Right now, there’s no solid clinical evidence that ivermectin and fenbendazole — separately or together — can reliably kill cancer in humans. And chances are that IF they were to kill cancer effectively, either separately or in combination, you'd never hear about it because they're both cheap to purchace. A $12.99 tube of Ivermectin paste has already jumped in price to around $22.00 due to the publicity just from social media. Yet, neither product would make the medical people rich without some real price gouging.
If you’re considering alternative or repurposed treatments, always talk to your oncologist first. The hope for new cancer cures is real and important, but it’s critical to separate science from hype.
Credits:
- American Cancer Society: What to Know About Fenbendazole
- Oncology News Central: Interest in Ivermectin for Cancer
- Patient Power: Ivermectin and Cancer: What the Data Really Shows
- NIH: Ivermectin’s Antitumor Effects
- Pharmacy Times: Controversial Antiparasitics in Cancer Care
